Track 6: Glaucoma: Visual field loss

Glaucoma is a multifactorial optic neuropathy that affects more than 50 million people and is the second leading cause of blindness worldwide. The role of intra ocular pressure (IOP) has been well documented as a major modifiable risk factor for glaucoma. Additionally, many glaucoma patients have a relatively low IOP, while some healthy individuals have a relatively high IOP. The disorders can be roughly divided into two main categories, open-angle glaucoma and closed-angle glaucoma. Impaired ocular blood flow regulation in open angle glaucoma as a risk of glaucoma has also been well established, especially over the past two decades. Pathophysiology of glaucoma indicates towards the increased in intraocular pressure which compresses and damages the optic nerve. Once the optic nerve is damaged, it fails to carry visual information to the brain and this result in loss of vision. The exact pathophysiology of glaucoma contributing to this is yet to be determined. Biomarkers for glaucoma have predictive use that could help and guide more specific therapy in some glaucoma patients. Endothelin in glaucoma treatment play a very key role in pathogenesis of glaucoma. Glaucoma accounts for over 10 million visits to physicians each year. In terms of Social Security benefits, lost income tax revenues, and health care expenditures, the cost to the U.S. government is estimated to be over $1.5 billion annually. The Glaucoma Research Society of Canada is the only Canadian non-profit organization solely dedicated to funding glaucoma research. Since 1989, it has raised more than two million dollars in support of 150 research projects. The Society funds 10 to 15% of all independent glaucoma research in Canada. Bascom Palmer and Wills Eye are the top researcher organization for glaucoma.7 Entrepreneurs Investment meet

 

  • Pathophysiology of Glaucoma
  • Open-angle Glaucoma
  • Biomarkers for Glaucoma
  • Endothelin in Glaucoma treatment
  • Complications and Management of Glaucoma Filtering
  • Closed-angle Glaucoma

Related Conference of Track 6: Glaucoma: Visual field loss

October 27-28, 2021

35th European Ophthalmology Congress

Zurich, Switzerland
October 28-28, 2021

4th World Eye and Vision Congress

Amsterdam, Netherlands
October 29-29, 2021

4th International Conference on Eye and Vision

Amsterdam, Netherlands
November 24-24, 2021

2nd International Conference on Optics and Photonics

Osaka, Japan
December 01-02, 2021

2nd World Congress on Ophthalmology & Optometry

Barcelona, Spain
December 02-02, 2021

4th World Congress on Eye and Vision

Paris, France
December 02-02, 2021

2nd International Conference on Glaucoma

Paris, France
December 03-03, 2021

International Conference on Euro Ophthalmology and Eye Surgery

Amsterdam, Netherlands
February 18-19, 2022

31st World Congress on Ophthalmology and Optometry

Rome, Italy
March 07-08, 2022

7th Global Pediatric Ophthalmology Congress

Barcelona, Spain
March 21-22, 2022

22nd Global Ophthalmologists Annual meeting

Amsterdam, Netherlands
April 11-12, 2022

2nd International Conference on Ophthalmology

Prague, Czech Republic
April 21-22, 2022

5th International Conference on Ear Nose and Throat

Amsterdam, Netherlands
April 26-27, 2022

European Conference on Ophthalmology & Eye care

Auckland, Newzealand
April 27-28, 2022

WORLDCONGRESS-OPTHALMOLOGY2022

Toronto, Canada
April 28-29, 2022

3rd International Conference on Optometry

Amsterdam, Netherlands
May 04-05, 2022

9th Global Ophthalmology Meeting

Prague, Czech Republic

Track 6: Glaucoma: Visual field loss Conference Speakers

Recommended Sessions

Related Journals

Are you interested in